Przemyslaw J Kotyla (Przemysław J Kotyla, P J Kotyla, Przemysław Kotyla)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Venues

International journal of environmental research and public health

International journal of molecular sciences

Journal of clinical medicine

Genes

Medical University of Silesia (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Medical University of Silesia Oct 01 1991

Poland

PHD :: Department of Internal Medicine Rheumatology and Clinical Immunology

Publications

Olga Gumkowska-Sroka, Kacper Kotyla, Przemyslaw J Kotyla
Immunogenetics of Systemic Sclerosis. Genes 15 (5) (2024)
Olga Gumkowska-Sroka, Kacper Kotyla, Przemyslaw J Kotyla
Immunogenetics of Systemic Sclerosis. Genes 15 (5) (2024)
Md Asiful Islam, Saleh Ahmed, Shabiha Sultana, Sayeda Sadia Alam, Tareq Hossan, Wesam Gouda, Faisal Alsaqabi, Rosline Hassan, Przemyslaw J Kotyla
Vitamin D Status in Patients with Primary Antiphospholipid Syndrome (PAPS): A Systematic Review and Meta-Analysis. Antibodies (Basel, Switzerland) 13 (1) (2024)
Olga Gumkowska-Sroka, Kacper Kotyla, Przemyslaw J Kotyla
Immunogenetics of Systemic Sclerosis. Genes 15 (5) (2024)
Md Asiful Islam, Saleh Ahmed, Shabiha Sultana, Sayeda Sadia Alam, Tareq Hossan, Wesam Gouda, Faisal Alsaqabi, Rosline Hassan, Przemyslaw J Kotyla
Vitamin D Status in Patients with Primary Antiphospholipid Syndrome (PAPS): A Systematic Review and Meta-Analysis. Antibodies (Basel, Switzerland) 13 (1) (2024)
Przemyslaw J Kotyla, Marzena Olesińska
Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus. International journal of molecular sciences 24 (11) (2023)
Olga Gumkowska-Sroka, Kacper Kotyla, Ewa Mojs, Klaudia Palka, Przemyslaw J Kotyla
Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis. Pharmaceuticals (Basel, Switzerland) 16 (8) (2023)
Katarzyna Warchol-Biedermann, Ewa Mojs, Dorota Sikorska, Przemyslaw J Kotyla, Grażyna Teusz, Włodzimierz Samborski
Psychological Implications to the Therapy of Systemic Lupus Erythematosus. International journal of environmental research and public health 19 (23) (2022)
Katarzyna Warchol-Biedermann, Ewa Mojs, Dorota Sikorska, Przemyslaw J Kotyla, Grażyna Teusz, Włodzimierz Samborski
Psychological Implications to the Therapy of Systemic Lupus Erythematosus. International journal of environmental research and public health 19 (23) (2022)
Przemyslaw J Kotyla, Olga Gumkowska-Sroka, Bartosz Wnuk, Kacper Kotyla
Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
Anna Chudek, Przemyslaw J Kotyla, Małgorzata Mossakowska, Tomasz Grodzicki, Tomasz Zdrojewski, Magdalena Olszanecka-Glinianowicz, Jerzy Chudek, Aleksander Jerzy Owczarek
The Prevalence of Anticitrullinated Protein Antibodies in Older Poles-Results from a Population-Based PolSenior Study. International journal of environmental research and public health 19 (21) (2022)
Katarzyna Warchol-Biedermann, Ewa Mojs, Dorota Sikorska, Przemyslaw J Kotyla, Grażyna Teusz, Włodzimierz Samborski
Psychological Implications to the Therapy of Systemic Lupus Erythematosus. International journal of environmental research and public health 19 (23) (2022)
Kornelia Kuźnik-Trocha, Katarzyna Winsz-Szczotka, Katarzyna Komosinska-Vassev, Agnieszka Jura-Półtorak, Adrian Miara, Przemyslaw J Kotyla, Krystyna Olczyk
Plasma and Urine Levels of Glycosaminoglycans in Patients with Systemic Sclerosis and Their Relationship to Selected Interleukins and Marker of Early Kidney Injury. Journal of clinical medicine 11 (21) (2022)
Katarzyna Warchol-Biedermann, Ewa Mojs, Dorota Sikorska, Przemyslaw J Kotyla, Grażyna Teusz, Włodzimierz Samborski
Psychological Implications to the Therapy of Systemic Lupus Erythematosus. International journal of environmental research and public health 19 (23) (2022)
Karolina Nowak, Olga Gumkowska-Sroka, Przemyslaw J Kotyla
Adhesion molecules: a way to understand lupus. Reumatologia 60 (2) (2022)
Przemyslaw J Kotyla, Małgorzata Engelmann, Joanna Giemza-Stokłosa, Bartosz Wnuk, Md Asiful Islam
Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role? International journal of molecular sciences 22 (5) (2021)
Przemyslaw J Kotyla, Md Asiful Islam
MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS). International journal of molecular sciences 21 (6) (2020)
Kornelia Kuźnik-Trocha, Katarzyna Winsz-Szczotka, Katarzyna Komosinska-Vassev, Agnieszka Jura-Półtorak, Anna Kotulska-Kucharz, Eugeniusz J Kucharz, Przemyslaw J Kotyla, Krystyna Olczyk
Plasma Glycosaminoglycan Profiles in Systemic Sclerosis: Associations with MMP-3, MMP-10, TIMP-1, TIMP-2, and TGF-Beta. BioMed research international 2020 (2020)
Przemyslaw J Kotyla, Md Asiful Islam, Małgorzata Engelmann
Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis. International journal of molecular sciences 21 (19) (2020)
Olga Gumkowska-Sroka, Krystyna Jagoda, Aleksander Jerzy Owczarek, Grzegorz Helbig, Joanna Giemza-Stokłosa, Przemyslaw J Kotyla
Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment. Journal of clinical medicine 8 (5) (2019)
Przemyslaw J Kotyla
Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure? International journal of molecular sciences 19 (6) (2018)
Przemyslaw J Kotyla
Simvastatin reduces antiphospholipid antibodies formation in patients with systemic lupus erythematosus: a preliminary study. Lupus 27 (9) (2018)
Przemyslaw J Kotyla
Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients? BioMed research international 2018 (2018)
Przemyslaw J Kotyla, Aneta Kruszec-Zytniewska, Aleksander Jerzy Owczarek, Magdalena Olszanecka-Gilianowicz, Jerzy Chudek
Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker. Journal of clinical medicine 7 (12) (2018)

Przemyslaw J Kotyla.css-eqlu8i{font-size:small;padding-left:4px;} (Przemysław J Kotyla, P J Kotyla, Przemysław Kotyla)

Publication Activity (10 Years)

Top Topics

Top Venues

Przemyslaw J Kotyla (Przemysław J Kotyla, P J Kotyla, Przemysław Kotyla)